340 related articles for article (PubMed ID: 31181209)
1. IMM-H007 improves heart function via reducing cardiac fibrosis.
Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
[TBL] [Abstract][Full Text] [Related]
2. IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway.
Wang SX; Feng YN; Feng S; Wu JM; Zhang M; Xu WL; Zhang YY; Zhu HB; Xiao H; Dong ED
Acta Pharmacol Sin; 2022 Oct; 43(10):2542-2549. PubMed ID: 35354962
[TBL] [Abstract][Full Text] [Related]
3. The cordycepin derivative IMM-H007 improves endothelial dysfunction by suppressing vascular inflammation and promoting AMPK-dependent eNOS activation in high-fat diet-fed ApoE knockout mice.
Wang MJ; Peng XY; Lian ZQ; Zhu HB
Eur J Pharmacol; 2019 Jun; 852():167-178. PubMed ID: 30826323
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
[TBL] [Abstract][Full Text] [Related]
5. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.
Zhao L; Mi Y; Guan H; Xu Y; Mei Y
Eur J Pharmacol; 2016 Jul; 783():33-46. PubMed ID: 27108788
[TBL] [Abstract][Full Text] [Related]
6. Gelsolin is an important mediator of Angiotensin II-induced activation of cardiac fibroblasts and fibrosis.
Jana S; Aujla P; Hu M; Kilic T; Zhabyeyev P; McCulloch CA; Oudit GY; Kassiri Z
FASEB J; 2021 Oct; 35(10):e21932. PubMed ID: 34549830
[TBL] [Abstract][Full Text] [Related]
7. AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.
Zhang N; Wei WY; Liao HH; Yang Z; Hu C; Wang SS; Deng W; Tang QZ
J Mol Med (Berl); 2018 Dec; 96(12):1345-1357. PubMed ID: 30341569
[TBL] [Abstract][Full Text] [Related]
8. [AMP-activated kinase activation inhibits transforming growth factor-β1 production in cardiac fibroblasts via targeting C/EBPβ].
Xiao H; Piao CS; Chen RF; Zhang YY
Sheng Li Xue Bao; 2017 Apr; 69(2):123-128. PubMed ID: 28435970
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II.
Ma F; Li Y; Jia L; Han Y; Cheng J; Li H; Qi Y; Du J
PLoS One; 2012; 7(5):e35144. PubMed ID: 22574112
[TBL] [Abstract][Full Text] [Related]
10. ALDH2 Activation Inhibited Cardiac Fibroblast-to-Myofibroblast Transformation Via the TGF-β1/Smad Signaling Pathway.
Yuan Q; Cao S; Dong Q; Wang Z; Xu Y; Han Q; Ma J; Wei S; Pang J; Yang F; Zhang R; Liu B; Dai S; Xue L; Wang J; Xue M; Xu T; Zheng W; Xu F; Chen Y; Guo P
J Cardiovasc Pharmacol; 2019 Apr; 73(4):248-256. PubMed ID: 30801261
[TBL] [Abstract][Full Text] [Related]
11. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
12. Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.
Chen R; Feng Y; Wu J; Song Y; Li H; Shen Q; Li D; Zhang J; Lu Z; Xiao H; Zhang Y
Br J Pharmacol; 2018 Apr; 175(8):1217-1229. PubMed ID: 28230250
[TBL] [Abstract][Full Text] [Related]
13. Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction.
Ma Y; Kuang Y; Bo W; Liang Q; Zhu W; Cai M; Tian Z
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830222
[TBL] [Abstract][Full Text] [Related]
14. Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo.
Chen X; Long L; Cheng Y; Chu J; Shen Z; Liu L; Li J; Xie Q; Liu H; Wu M; Chen Y; Peng J; Shen A
Biomed Pharmacother; 2021 May; 137():111318. PubMed ID: 33556875
[TBL] [Abstract][Full Text] [Related]
15. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis.
Meng G; Zhu J; Xiao Y; Huang Z; Zhang Y; Tang X; Xie L; Chen Y; Shao Y; Ferro A; Wang R; Moore PK; Ji Y
Oxid Med Cell Longev; 2015; 2015():691070. PubMed ID: 26078813
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.
Hong SK; Choo EH; Ihm SH; Chang K; Seung KB
Metabolism; 2017 Nov; 76():42-55. PubMed ID: 28987239
[TBL] [Abstract][Full Text] [Related]
18. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
19. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
20. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
Hermida N; Markl A; Hamelet J; Van Assche T; Vanderper A; Herijgers P; van Bilsen M; Hilfiker-Kleiner D; Noppe G; Beauloye C; Horman S; Balligand JL
Cardiovasc Res; 2013 Jul; 99(1):44-54. PubMed ID: 23542580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
